Cargando…

Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer

INTRODUCTION: Toll-like receptors (TLRs) are a family of pattern recognition receptors that are expressed on cells of the innate immune system. The ligands can be pathogen derived (pathogen associated molecular patterns; PAMPs) or endogenous (damage associated molecular patters; DAMPs) that when bou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mehmeti, Meliha, Allaoui, Roni, Bergenfelz, Caroline, Saal, Lao H., Ethier, Stephen P., Johansson, Martin E., Jirström, Karin, Leandersson, Karin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578669/ https://www.ncbi.nlm.nih.gov/pubmed/26392082 http://dx.doi.org/10.1186/s13058-015-0640-x

Ejemplares similares

S100A9 expressed in ER(−)PgR(−) breast cancers induces inflammatory cytokines and is associated with an impaired overall survival
por: Bergenfelz, Caroline, et al.
Publicado: (2015)

Clinical relevance of systemic monocytic-MDSCs in patients with metastatic breast cancer
por: Bergenfelz, Caroline, et al.
Publicado: (2020)

Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers
por: Allaoui, Roni, et al.
Publicado: (2016)

Infiltration of [Formula: see text] T cells, IL-17 [Formula: see text] T cells and FoxP3 [Formula: see text] T cells in human breast cancer
por: Allaoui, Roni, et al.
Publicado: (2018)

Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer
por: Chan, Melissa, et al.
Publicado: (2015)

Wnt5a is a TLR2/4-ligand that induces tolerance in human myeloid cells
por: Mehmeti, Meliha, et al.
Publicado: (2019)

Elevated Resistin Gene Expression in African American Estrogen and Progesterone Receptor Negative Breast Cancer
por: Vallega, Karin A., et al.
Publicado: (2016)

Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
por: Hefti, Marco M, et al.
Publicado: (2013)

Progesterone and Estrogen Receptors in Neurofibromas of Patients with NF1
por: Geller, Mauro, et al.
Publicado: (2008)

The Generation and Identity of Human Myeloid-Derived Suppressor Cells
por: Bergenfelz, Caroline, et al.
Publicado: (2020)

Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Markers in Endometrial Cancer
por: Wang, Caifeng, et al.
Publicado: (2020)

Toll-like receptor 4 as a predictor of clinical outcomes of estrogen receptor-negative breast cancer in Saudi women
por: Semlali, Abdelhabib, et al.
Publicado: (2017)

Effects of Single-Nucleotide Polymorphisms in Cytokine, Toll-Like Receptor, and Progesterone Receptor Genes on Risk of Miscarriage
por: Razdaibiedina, Anastasiia, et al.
Publicado: (2018)

Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer
por: Yu, Ke-Da, et al.
Publicado: (2015)

Estrogen Receptor Mutations and Changes in Estrogen Receptor and Progesterone Receptor Protein Expression in Metastatic or Recurrent Breast Cancer
por: Umekita, Yoshihisa, et al.
Publicado: (1998)

Unliganded Progesterone Receptor Governs Estrogen Receptor Gene Expression by Regulating DNA Methylation in Breast Cancer Cells
por: Verde, Gaetano, et al.
Publicado: (2018)

Progesterone receptor modulates estrogen receptor-α action in breast cancer
por: Mohammed, Hisham, et al.
Publicado: (2015)

Prognostic Significance of Single Progesterone Receptor Positivity: A Comparison Study of Estrogen Receptor Negative/Progesterone Receptor Positive/Her2 Negative Primary Breast Cancer With Triple Negative Breast Cancer
por: Fan, Ying, et al.
Publicado: (2015)

Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors
por: Wiebe, John P, et al.
Publicado: (2013)

Survival Benefit of Tamoxifen in Estrogen Receptor-Negative and Progesterone Receptor-Positive Low Grade Breast Cancer Patients
por: Yang, Li-Heng, et al.
Publicado: (2012)

A model of spontaneous mouse mammary tumor for human estrogen receptor- and progesterone receptor-negative breast cancer
por: ZHENG, LIXIANG, et al.
Publicado: (2014)

RAB6C is an independent prognostic factor of estrogen receptor-positive/progesterone receptor-negative breast cancer
por: Fohlin, Helena, et al.
Publicado: (2020)

Genomic Landscape and Endocrine-Resistant Subgroup in Estrogen Receptor-Positive, Progesterone Receptor-Negative, and HER2-Negative Breast Cancer
por: Liu, Xi-Yu, et al.
Publicado: (2018)

Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha
por: Perkins, Meghan S., et al.
Publicado: (2022)

Estrogen and Progesterone Receptors in Endometrium in Women with Unexplained Infertility
por: Godinjak, Zulfo, et al.
Publicado: (2014)

Distribution of estrogen and progesterone receptors isoforms in endometrial cancer
por: Kreizman-Shefer, Hila, et al.
Publicado: (2014)

RIME proteomics of estrogen and progesterone receptors in breast cancer
por: D’Santos, Clive, et al.
Publicado: (2015)

Expression of estrogen and progesterone receptors in papillary thyroid carcinoma
por: Jalali-Nadoushan, Mohammad-Reza, et al.
Publicado: (2016)

High Expression of Sphingosine Kinase 1 in Estrogen and Progesterone Receptors-Negative Breast Cancer
por: Nazouri, Azadeh-Sadat, et al.
Publicado: (2017)

Estrogen Receptor, Progesterone Receptor, and HER-2 Expression in Recurrent Pleomorphic Adenoma
por: de Souza, Ana Amélia, et al.
Publicado: (2019)

Expression of Estrogen Receptor- and Progesterone Receptor-Regulating MicroRNAs in Breast Cancer
por: Kalinina, Tatiana, et al.
Publicado: (2021)

The expression of stanniocalcin-1, estrogen receptor and progesterone receptor in endometrioid endometrial cancer
por: Erkılınç, Gamze, et al.
Publicado: (2023)

Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers
por: Jumppanen, Mervi, et al.
Publicado: (2007)

Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesions
por: Burrai, Giovanni P, et al.
Publicado: (2010)

Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study
por: Wei, Jin-Li, et al.
Publicado: (2018)

On the origin of myeloid-derived suppressor cells
por: Millrud, Camilla Rydberg, et al.
Publicado: (2016)

Toll-Like Receptors: Are They Taking a Toll on the Heart in Viral Myocarditis?
por: Favere, Kasper, et al.
Publicado: (2021)

Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
por: Xun, Yang, et al.
Publicado: (2021)

Leptin receptor expression during the progression of endometrial carcinoma is correlated with estrogen and progesterone receptors
por: Méndez-López, Luis Fernando, et al.
Publicado: (2016)

CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer
por: Dahlgren, Malin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2avru8gvnd3in3u42toi0alh1n